Oncternal Therapeutics Income Statement

Financials in millions MAD. Fiscal year is January - December.

Millions MAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Revenue	78.58	61.9	53.91	65.01	194.19	Upgrade
Revenue Growth (YoY)	26.95%	14.83%	-17.08%	-66.52%	4.88%	Upgrade
Cost of Revenue	66.01	66.12	57.43	71.87	69.73	Upgrade
Gross Profit	12.58	-4.22	-3.53	-6.86	124.46	Upgrade
Other Operating Expenses	22.91	41.11	25.2	20.05	58.93	Upgrade
Operating Expenses	22.91	41.11	25.2	20.05	58.93	Upgrade
Operating Income	-10.33	-45.33	-28.73	-26.92	65.53	Upgrade
Interest Expense	-0.29	-	-	-	-	Upgrade
Interest & Investment Income	-	2.58	3.14	1.14	6.69	Upgrade
Other Non Operating Income (Expenses)	-	-0	-	-	-	Upgrade
EBT Excluding Unusual Items	-10.62	-42.75	-25.59	-25.77	72.22	Upgrade
Other Unusual Items	-9.39	-0.81	0.11	10.07	-4.32	Upgrade
Pretax Income	-20.02	-43.56	-25.47	-15.71	67.9	Upgrade
Income Tax Expense	1.59	1.44	2.67	4.17	32.62	Upgrade
Earnings From Continuing Operations	-21.6	-45	-28.14	-19.87	35.28	Upgrade
Minority Interest in Earnings	6.83	11.38	8.28	9.42	-0.59	Upgrade
Net Income	-14.78	-33.61	-19.87	-10.45	34.69	Upgrade
Net Income to Common	-14.78	-33.61	-19.87	-10.45	34.69	Upgrade
Net Income Growth	-	-	-	-	15.66%	Upgrade
Shares Outstanding (Basic)	1	1	1	1	1	Upgrade
Shares Outstanding (Diluted)	1	1	1	1	1	Upgrade
Shares Change (YoY)	0.01%	0.00%	-0.02%	0.02%	0.00%	Upgrade
EPS (Basic)	-22.81	-51.89	-30.67	-16.13	53.56	Upgrade
EPS (Diluted)	-22.81	-51.89	-30.67	-16.13	53.56	Upgrade
EPS Growth	-	-	-	-	15.65%	Upgrade
Free Cash Flow	-41.1	-3.3	-7.25	9.7	124.22	Upgrade
Free Cash Flow Per Share	-63.44	-5.09	-11.19	14.96	191.78	Upgrade
Gross Margin	16.00%	-6.82%	-6.54%	-10.56%	64.09%	Upgrade
Operating Margin	-13.15%	-73.24%	-53.29%	-41.40%	33.75%	Upgrade
Profit Margin	-18.80%	-54.30%	-36.85%	-16.07%	17.87%	Upgrade
Free Cash Flow Margin	-52.30%	-5.33%	-13.45%	14.91%	63.97%	Upgrade
EBITDA	-	-	-	-26.48	65.97	Upgrade
EBITDA Margin	-	-	-	-40.73%	33.97%	Upgrade
D&A For EBITDA	-	-	-	0.44	0.44	Upgrade
EBIT	-10.33	-45.33	-28.73	-26.92	65.53	Upgrade
EBIT Margin	-13.15%	-73.24%	-53.29%	-41.40%	33.75%	Upgrade
Effective Tax Rate	-	-	-	-	48.04%	Upgrade

Updated May 2, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.